Discover Verona Pharma's Q1 2025 earnings report, featuring Ohtuvayre's rapid adoption, sales milestones, and global expansion.

Q1 2025 Management View CEO Drew Marsh highlighted significant progress in customer growth, industrial sales, and strategic ...

Q1 2025 Management View CEO Mark Manheimer highlighted progress in reducing tenant concentration, with the top five tenants ...

Senior and assisted living communities owner Welltower kicked off the year with a boost in income while it expands its ...

After a review of market data, the CFPB finalized a rule that would have capped late fees at $8 and ended automatic inflation ...

On April 24 this reporter posted an article titled “How much was Elon Musk’s pledge to step back from DOGE worth? $67 billion ...

Coke moderated expectations for its full-year profit Tuesday. The company said it now expects full-year adjusted earnings to ...

The auto industry finally received some clarity from the White House, with a few exemptions coming to President Trump’s auto ...

Brazil's central government posted a smaller-than-expected March primary budget surplus, Treasury data showed on Tuesday, but ...

General Motors posted strong financial results for its first quarter Tuesday, but says it will reassess its expectations for ...

Financial news including quarterlies, annuals, and regulatory actions about biometrics and digital identity firm Idex ...

Beyond Inc. shifts to growth mode after cost cuts, with Bed Bath & Beyond driving revenues, new store formats planned, and a ...